Form 4: Agilon Health Executive Reports Stock Transactions

Agilon Health, Inc. executive Timothy Patrick O'Rourke reported transactions involving restricted stock units and performance stock units.

Summary

• Timothy Patrick O'Rourke, CEO & President and Director of agilon health, inc., reported the acquisition of securities on May 7, 2026.
• The transactions involved 120,000 restricted stock units (RSUs) and 200,000 performance stock units (PSUs).
• The RSUs vest in three equal installments on each anniversary of May 7, 2026, contingent upon continued employment.
• The PSUs have a three-year performance period, with vesting dependent on achieving specific 30-trading-day weighted average stock prices ($50, $100, and $150) and continued employment.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents standard executive compensation and equity awards rather than new financial performance or strategic shifts.

Positives

• Acquisition of 120,000 restricted stock units by a key executive, indicating continued commitment.
• Potential for significant equity awards through performance stock units, tied to stock price appreciation.
• The structure of PSUs incentivizes long-term stock price growth, aligning executive interests with shareholders.

Negatives

• The performance stock units are subject to strict price targets and continued employment, creating uncertainty in vesting.
• The earliest transaction date is May 7, 2026, which is in the future relative to the filing date, suggesting a pre-planned or grant-related event.

Risks

• Failure to meet the specified 30-trading-day weighted average stock prices ($50, $100, $150) will result in forfeiture of performance stock units.
• Continued employment is a condition for vesting of both restricted stock units and performance stock units, posing a risk if the executive departs.
• The future nature of the transaction date (May 7, 2026) implies these are planned grants or awards rather than current market activity.

Future Outlook

The vesting of performance stock units is contingent upon the company's stock price reaching $50, $100, and $150 thresholds over a three-year period, indicating a positive outlook is tied to significant stock appreciation.

Industry Context

StockSavvy.ai notes that this Form 4 filing by a key executive at agilon health, inc. (AGL) details equity awards, a common practice in the healthcare services sector to attract and retain talent and align incentives with long-term performance and shareholder value.

Stakeholder Impact

• Shareholders: The performance stock units incentivize management to drive stock price appreciation, potentially benefiting shareholders if targets are met.
• Employees: The vesting of RSUs and PSUs is contingent on continued employment, highlighting the importance of employee retention for the company's leadership.
• Management: The executive is subject to vesting conditions tied to both continued employment and stock performance.

Next Steps

• Continued employment through the vesting dates for restricted stock units.
• Attainment of specific 30-trading-day weighted average stock prices ($50, $100, $150) for performance stock unit vesting.
• Continued employment through the end of the three-year performance period for performance stock units.

Key Dates

Keywords

agilon health, AGL, Form 4, insider trading, stock options, restricted stock units, performance stock units, executive compensation, Timothy Patrick O'Rourke, SEC filing